Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 105
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Wound Care ; 33(Sup4a): lxxxv-xc, 2024 Apr 02.
Article in English | MEDLINE | ID: mdl-38588057

ABSTRACT

Biosurgery (larval therapy) has been used for centuries. However, in recent times, this treatment has been replaced with the use of antibiotics for the treatment of wounds. Due to increasing antibiotic resistance, larval therapy is once again coming to the fore as an effective and efficient treatment. Due to the increasing ageing population, along with an increase in patients with arterial occlusive disease, diabetes and immobility, the number of patients with hard-to-heal wounds will increase. The stressors associated with wounds, such as pain, limited physical functionality, depression and social withdrawal, have a negative impact on patient quality of life. This case report documents the performance of biosurgery in a patient with multimorbidities.


Subject(s)
Diabetic Foot , Foot Ulcer , Humans , Debridement , Diabetic Foot/surgery , Quality of Life , Wound Healing , Foot Ulcer/surgery , Bacteria
2.
Int Wound J ; 21(2): e14416, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37770025

ABSTRACT

There is an increasing use of non-medicated wound dressing with claims of irreversible bacterial binding. Most of the data are from in vitro models which lack clinical relevance. This study employed a range of in vitro experiments to address this gap and we complemented our experimental designs with in vivo observations using dressings obtained from patients with diabetes-related foot ulcers. A hydrophobic wound dressing was compared with a control silicone dressing in vitro. Test dressings were placed on top of a Pseudomonas aeruginosa challenge suspension with increasing concentrations of suspension inoculum in addition to supplementation with phosphate buffered saline (PBS) or increased protein content (IPC). Next, we used the challenge suspensions obtained at the end of the first experiment, where bacterial loads from the suspensions were enumerated following test dressing exposure. Further, the time-dependent bacterial attachment was investigated over 1 and 24 h. Lastly, test dressings were exposed to a challenge suspension with IPC, with or without the addition of the bacteriostatic agent Deferiprone to assess the impacts of limiting bacterial growth in the experimental design. Lastly, two different wound dressings with claims of bacterial binding were obtained from patients with chronic diabetes-related foot ulcers after 72 h of application and observed using scanning electron microscope (SEM). Bacteria were enumerated from each dressing after a 1-h exposure time. There was no statistical difference in bacterial attachment between both test dressings when using different suspension inoculum concentrations or test mediums. Bacterial attachment to the two test dressings was significantly lower (p < 0.0001) when IPC was used instead of PBS. In the challenge suspension with PBS, only the hydrophobic dressing achieved a statistically significant reduction in bacterial loads (0.5 ± 0.05 log colony forming units; p = 0.001). In the presence of IPC, there was no significant reduction in bacterial loads for either test dressing. When bacterial growth was arrested, attachment to the test dressings did not increase over time, suggesting that the number of bacteria on the test dressings increases over time due to bacterial growth. SEM identified widespread adsorption of host fouling across the test dressings which occurred prior to microbial binding. Therein, microbial attachment occurred predominantly to host fouling and not directly to the dressings. Bacterial binding is not unique to dialkylcarbamoyl chloride (DACC) dressings and under clinically relevant in vitro conditions and in vivo observations, we demonstrate (in addition to previously published work) that the bacterial binding capabilities are not effective at reducing the number of bacteria in laboratory models or human wounds.


Subject(s)
Anti-Infective Agents , Diabetic Foot , Foot Ulcer , Humans , Diabetic Foot/drug therapy , Anti-Infective Agents/therapeutic use , Bandages , Bacteria
3.
Medicine (Baltimore) ; 102(45): e35969, 2023 Nov 10.
Article in English | MEDLINE | ID: mdl-37960782

ABSTRACT

INTRODUCTION: Rheumatoid vasculitis (RV) is a frequently encountered complication of rheumatoid arthritis (RA), wherein skin vasculitis lesions are observed as a common clinical manifestation, encompassing skin purpura, erythema, vascular occlusion, ulcers, and gangrene. As a matter of fact, it marks the most severe extra-articular manifestation of RA. And the resultant ulcers tend to pose a greater challenge with regard to therapeutic interventions. We report a case of RV complicated by refractory foot ulcer that was successfully treated with puncture. CASE PRESENTATION: A 62-year-old man with RV caused by RA developed refractory foot ulcers. Despite the application of topical antibiotics, the wound gradually expanded and remained unhealed for 7 months. Consequently, the patient sought an integrated therapeutic approach involving Traditional Chinese Medicine and was subsequently treated with acupuncture. After 12 weeks of acupuncture, the foot ulcers healed completely. CONCLUSION: Acupuncture has the potential to facilitate wound healing and may serve as a viable alternative treatment modality for wounds unresponsive to traditional therapeutic interventions.


Subject(s)
Acupuncture Therapy , Arthritis, Rheumatoid , Foot Ulcer , Humans , Male , Middle Aged , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/therapy , Foot Ulcer/complications , Foot Ulcer/therapy , Rheumatoid Vasculitis/complications
4.
Wound Repair Regen ; 31(4): 528-541, 2023.
Article in English | MEDLINE | ID: mdl-37078427

ABSTRACT

This pilot randomised controlled study (RCT) aimed to assess the feasibility and acceptability of a progressive muscle relaxation with guided imagery intervention (experimental group [EG]) compared to a neutral guided imagery placebo (active control group [ACG]) and standard care to diabetic foot ulcer [DFU] treatment (passive control group [PCG]), to decide on the need for a definitive RCT. Diabetic foot patients with one or two chronic DFU and significant levels of stress/anxiety/depression were recruited and assessed during a period of 6 months, at three moments. Primary outcomes: feasibility rates and satisfaction with relaxation sessions. Secondary outcomes: DFU healing score, DFU-related quality of life (DFUQoL), physical and mental HRQoL, stress and emotional distress, DFU representations, arterial blood pressure, and heart rate. A total of 146 patients completed the baseline (T0) assessment with 54 participants presenting significant distress being randomised into three groups. Patients were assessed 2 months post-intervention (T1) and 4 months after T1 (T2). Feasibility rates showed reduced values on eligibility, recruitment and inclusion in the study, although with an acceptable rate of refusal lower than 10%. On average, participants reported being satisfied with relaxation sessions and recommended them to other patients. Differences between groups showed that, at T1, PCG participants reported higher levels of stress than those from EG and ACG. Within-group differences showed improvements in stress, distress, DFUQoL and DFU extent over time only in EG and ACG. Only EG showed significant changes in DFU representations at T1. The results suggest that relaxation may be a promising coping strategy to deal with DFU distress and an important adjuvant therapy for DFU healing, supporting the implementation of a definitive RCT.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Foot Ulcer , Humans , Pilot Projects , Wound Healing , Quality of Life
5.
Int J Low Extrem Wounds ; 22(3): 466-474, 2023 Sep.
Article in English | MEDLINE | ID: mdl-34213957

ABSTRACT

Background. Chronic foot ulcers are a major cause of morbidity in people with diabetes with a lifetime risk of 25%. Treatment is challenging and the recurrence rates of foot ulcers are >50% after 3 years. Vitamin D deficiency is more common in people with diabetes with chronic foot ulcers, compared to both people without diabetes as well as people with diabetes but without foot ulcers. Purpose/aim of study. To assess the efficacy of high-dose compared to low-dose Cholecalciferol vitamin D3 on healing of chronic diabetic foot ulcers. Materials and methods. We included people with diabetes with one or more foot ulcers lasting for more than 6 weeks. Patients were randomly allocated to either a daily oral intake of high-dose (170 µg) or low-dose (20 µg) vitamin D3 (Cholecalciferol). We saw patients in the outpatient clinic after 4, 12, 24, 36, and 48 weeks. At each visit, we measured the ulcer with a specialized camera, and associated software and the area (cm2) was calculated. Patients and assessors were blinded to treatment allocation. We followed all patients for 48 weeks or until wound healing or surgical treatment. Findings/results. We included 48 patients in the analysis (24 in each group), with a total of 64 ulcers. Among them 41 ulcers were followed until healing or 48-week follow-up and 20 ulcers were surgically treated during the study period. Three patients were lost for follow-up. The intention-to-treat analysis showed a significantly higher rate of ulcer healing in the high-dose group with 21 of 30 (70%) healed ulcers compared to 12 of 34 (35%) in the low-dose group (P = .012). Median ulcer reduction at final follow-up was 100% (interquartile range [IQR]: 72-100) in the high-dose group and 57% (IQR: -28 to 100) in the low-dose group. Furthermore, we found a significant effect of high-dose vitamin D on ulcer reduction in the repeated measures analysis of variance. Conclusions. We found high-dose vitamin D3 to be efficient, compared to low-dose vitamin D3, in promoting healing in chronic diabetic foot ulcers.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Foot Ulcer , Humans , Diabetic Foot/diagnosis , Diabetic Foot/drug therapy , Vitamin D/therapeutic use , Wound Healing , Vitamins , Cholecalciferol
6.
Diabet Med ; 40(1): e14951, 2023 01.
Article in English | MEDLINE | ID: mdl-36054775

ABSTRACT

OBJECTIVE: Diabetes-related foot ulceration (DFU) is a common limb-threatening condition, which is complex and subsequently challenging to manage. The aim of this study was to determine the contribution of a range of clinical and social factors to the healing of diabetes-related foot ulceration in an Australian population. RESEARCH DESIGN AND METHODS: This was a prospective cohort study of individuals with diabetes-related foot ulceration (DFU). Age, sex, medical history, medications, dietary supplementation (e.g. vitamin C intake) and smoking history were elicited at baseline. The index of relative socio-economic disadvantage (IRSD) was calculated. The Australian Eating Survey and International Physical Activity Questionnaire-short were administered. Wound history, size, grade, time to healing and infection were captured and monitored over 6 months. Logistic regression was performed to determine the relationship between healing and diet quality, toe systolic pressure, wound size at, IRSD, infection and previous amputation. RESULTS: A total of 117 participants were included. The majority were male n = 96 (82%), socio-economically disadvantaged (mean IRSD 965, SD 60), and obese (BMI 36 kg/m2 , SD 11) with a long history of diabetes (20 years, SD 11). Wounds were predominantly neuropathic (n = 85, 73%) and classified 1A (n = 63, 54%) on the University of Texas wound classification system with few infections (n = 23, 16%). Dietary supplementation was associated with 4.36 increased odds of healing (95% 1.28-14.84, p = 0.02), and greater levels of socio-economic advantage were also associated with increased odds of healing (OR 1.01, 95% CI 1.01-1.02, p = 0.03). CONCLUSIONS: In this cohort study of predominantly neuropathic, non-infected DFU, individuals who had greater levels of socio-economic advantage had significantly greater odds of DFU healing. Diet quality was poor in most participants, with individuals taking supplementation significantly more likely to heal.


Subject(s)
Diabetes Mellitus , Diabetic Foot , Foot Ulcer , Adult , Male , Humans , Female , Diabetic Foot/epidemiology , Diabetic Foot/therapy , Cohort Studies , Prospective Studies , Australia/epidemiology , Wound Healing
7.
Rev. baiana saúde pública ; 45(3,supl.n.esp): 66-78, 28 dec. 2021.
Article in English | LILACS | ID: biblio-1352330

ABSTRACT

Hyperbaric oxygenation (HBO2) is a successful treatment of diabetic foot ulcerations. Research on the characterization of tissue by ultrasonography (CATUS) or by imaging (CATIM) has grown. We investigated the photographic pCATIM feasibility to quantitate HBO2 effects. Besides, we analyzed pre and post HBO2 treatment photographs quantitatively based on pixel brightnesses of gray-scale imaging versions. Grayscale Medians (GSM) for (1) entire ulceration, (2) inner core, (3) ulceration border, and (4) adjacent skin decreased from 92 to 77, 60 to 56, 105 to 101, and 105 to 90. Entire ulceration post-HBO2 pixel percentages were lower in the 112-153 intervals, 11% vs 29% (p = .0013 by Chi-square), and higher in the 41-111 brightness range, 87% vs 68% (p = .0008). A case report showed quantifiable relative changes detected by pCATIM post HBO2 treatment of diabetic foot ulceration. Further investigation may quantify brightness variabilities and/or specific GSM for ulceration and skin regions.


A oxigenioterapia hiperbárica (HBO2) tem sido um tratamento de sucesso para úlceras do pé diabético, enquanto cresce o número de pesquisas caracterizando o tecido por meio de ultrassonografia (Catus) ou imagem (Catim) ­ sendo que a pCatim torna viável quantificar os efeitos da oxigenioterapia hiperbárica. Fotografias do pré e pós tratamento foram analisadas quantitativamente com base em brilhos de pixel de versões de imagens em escala de cinza. Houve redução das medianas da escala de cinza (gray scale medians ­ GSM) para (1) ulceração inteira, de 92 para 77; (2) núcleo interno, de 60 para 56; (3) borda da ulceração, de 105 para 101; e (4) pele adjacente, de 105 para 90. Na úlcera completa, após a HBO2, as porcentagens de pixels foram menores nos intervalos 112-153 (11% contra 29%, p = 0,0013 por qui-quadrado) e maiores na faixa de brilho 41-111 (87% contra 68%, p = 0,0008). Um relato de caso demonstrou mudanças relativas quantificáveis detectadas por pCatim após o tratamento com HBO2 de uma úlcera do pé diabético, e investigações mais aprofundadas podem quantificar as variabilidades de brilho e/ou GSM específicas para cada ulceração e regiões da pele.


La oxigenación hiperbárica (HBO2) ha sido un tratamiento exitoso de las ulceraciones del pie diabético. Ha crecido la investigación sobre la caracterización de tejidos por ecografía (CATUS) o por imágenes (CATIM). Se investigó la viabilidad fotográfica de pCATIM para cuantificar los efectos de HBO2. Las fotografías anteriores y posteriores al tratamiento con HBO2 se analizaron cuantitativamente en función del brillo de los píxeles de las versiones de imágenes en escala de grises. Medianas de escala de grises (GSM) para (1) ulceración completa, (2) núcleo interno, (3) borde de ulceración y (4) piel adyacente disminuyeron de 92 a 77, 60 a 56, 105 a 101 y 105 a 90, respectivamente. En la ulceración completa, después de HBO2, los porcentajes de píxeles fueron más bajos en los intervalos 112-153, 11% vs 29% (p = .0013 por Chi-cuadrado) y más altos en el rango de brillo 41-111, 87% vs 68% (p = .0008). Un informe de caso demostró cambios relativos cuantificables detectados por pCATIM después del tratamiento con HBO2 de una ulceración del pie diabético. Una investigación adicional puede cuantificar las variaciones de brillo y o GSM específico para ulceraciones y regiones de la piel.


Subject(s)
Foot Ulcer , Diabetic Foot , Research Report , Hyperbaric Oxygenation
8.
An. Fac. Cienc. Méd. (Asunción) ; 54(1): 93-100, 20210000.
Article in Spanish | LILACS | ID: biblio-1178639

ABSTRACT

El 15% de los individuos con DM2 presenta una úlcera en el pie y una fracción importante de ellos sufrirá en algún momento una amputación. Se realizó un estudio analítico, de corte trasversal retrospectivo de muestreo no probabilístico de casos consecutivos en pacientes con diagnóstico de pie diabético que acudieron al servicio de Urgencias del Hospital de Clínicas de San Lorenzo, en el periodo Enero ­ Diciembre del año 2019. Sobre un número total de 138 pacientes, se observa que el 51% recibió un manejo quirúrgico, con amputaciones de varios tipos. Se comparó el manejo instaurado en los pacientes, sea este quirúrgico o conservador según la presencia o no de ciertas comorbilidades, como edad mayor a 65 años, lugar de procedencia, glicemia capilar promedio del paciente e hipertensión arterial al ingreso; de estos existió una relación estadísticamente significativa (p<0,05) entre la necesidad de amputación y la glicemia capilar y la hipertensión arterial. El éxito de la intervención requiere un completo entendimiento de la patogénesis de las úlceras del pie diabético y una implementación rápida y estandarizada de un tratamiento efectivo. El manejo multidisciplinario puede lograr el salvataje de la extremidad, que conducirá a una mejor calidad de vida y sobrevida.


Among diabetic patients, 15% have a foot ulcer and a significant fraction of them will suffer an amputation at some point. An analytical, retrospective cross-sectional study of non-probabilistic sampling of consecutive cases was carried out in patients with a diagnosis of diabetic foot who attended the Emergency Service of the Clínicas Hospital in San Lorenzo, during January - December of the year 2019. In a total of 138 patients, the management established in the patients, whether surgical or. conservative, was compared according to certain comorbidities, such as age over 65 years, place of origin, average capillary glycemia and arterial hypertension on admission; Of these, there was a statistically significant relationship (p <0.05) between the need for amputation and capillary glycemia and arterial hypertension. Successful intervention requires a thorough understanding of the pathogenesis of diabetic foot ulcers and a rapid and standardized implementation of effective treatment. Multidisciplinary management can achieve limb salvage, leading to better quality of life and survival.


Subject(s)
Ulcer , Homeopathic Pathogenesy , Foot Ulcer , Diabetic Foot , Amputation, Surgical , Hypertension , Cross-Sectional Studies , Diagnosis
9.
Medicine (Baltimore) ; 99(12): e19502, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32195951

ABSTRACT

BACKGROUND: Diabetic foot (DF) problems are common throughout the world, about one-fourth of them develop a foot ulcer and serious cases would suffer from amputation, which seriously affects the patient's work and life. Previous studies indicated that acupuncture as adjuvant therapy would be effective in treating DF. However, these studies have no consistent results. Therefore, the aim of our study was to explore the efficacy and safety of acupuncture as adjuvant therapy for DF. METHODS: The randomized controlled trials associated with acupuncture therapy (or as adjuvant therapy) for DF will be included. We will search 6 electronic databases relevant to health sciences, including PubMed, Embase, the Cochrane Library, the Chinese databases Sino-Med, CNKI, and WANFANG database. All searches were from databases inception to March 30, 2019. The primary outcomes are the total curative effective rate, and the hemodynamic parameter and adverse events will be deemed as secondary outcomes. The Stata15.1 software and Review Manager (RevMan 5.3; Cochrane Collaboration, Copenhagen, Denmark) will be used for analysis, to assess the bias risk, subgroup analysis, and data synthesis. RESULTS: In this systematic review and meta-analysis, we will synthesize the studies to assess the safety and efficacy of acupuncture as adjuvant therapy for DF. CONCLUSION: The summary of our study will clarify whether acupuncture as adjuvant therapy could be an efficient method for DF.


Subject(s)
Acupuncture Therapy/methods , Diabetic Foot/complications , Diabetic Foot/therapy , Foot Ulcer/complications , Amputation, Surgical , Diabetes Complications/pathology , Diabetes Mellitus/epidemiology , Diabetic Foot/epidemiology , Female , Humans , Male , Prevalence , Randomized Controlled Trials as Topic , Treatment Outcome
10.
Brazilian Journal of Development ; 6(8): 58274-58286, 2020.
Article in Portuguese | MTYCI | ID: biblio-1280805

ABSTRACT

Úlcera do pé diabético é uma das complicações de diabetes mellitus que ocorre por causas multifatoriais. A abordagem multidisciplinar e multiprofissional do paciente com pé diabético é recomendada, uma vez que a afecção possui alta prevalência e que as ações de prevenção e controle das lesões são potencialmente eficazes. Há um crescente interesse da comunidade científica e boa aceitação do tratamento com ozônio pelas revistas acadêmicas, apesar de o número de pesquisas acerca do assunto não ser amplo. Desse modo, o objetivo da presente pesquisa foi avaliar a influência da ozonioterapia em pacientes com feridas do pé diabético. Metodologia: Tratou-se de revisão narrativa de literatura acerca da terapia com ozônio para tratamento de ferida do pé diabético. Foram utilizados os termos "ozônio", "ozônioterapia", "ozonização", "pé diabético", úlcera do pé diabético", bem como suas traduções para o inglês "ozone", "ozonetherapy", "diabetic foot", "diabetic foot ulcer". Foram consultadas as bases acadêmicas PubMed, Scielo, Lilacs e EBSCOhost. Resultados/Discussão: Muitas vezes o tratamento convencional para feridas é ineficiente devido à multiplicação de bactérias resistentes. Para feridas infectadas, primeiramente pode-se empregar o ozônio como desinfetante, pois o gás é tanto bactericida como fungicida, e para se obter uma ferida livre de patógenos; posteriormente, pode-se aplicar doses baixas da mistura gasosa oxigênio-ozônio para acelerar a cicatrização da lesão. Dentre as formas de tratamento com ozônio estão a utilização de óleo ozonizado sobre a ferida e a aplicação local de uma mistura de gases ozônio e oxigênio diretamente sobre a úlcera. Além disso, o ozônio funciona bem quando insuflado em microambiente controlado (saco plástico). a ozonização, quando comparada ao uso de antibióticos convencionais, pode reduzir o tamanho das lesões e abreviar o tempo de internação dos pacientes a curto prazo, mas aparentemente não promove a cura total da úlcera nem reduz o número de complicações. Conclusão: Há um crescente interesse pela comunidade científica e boa aceitação do tratamento com ozônio pelas revistas acadêmicas, apesar de o número de pesquisas acerca do assunto não ser grande. Diversos trabalhos demonstraram resultados positivos da utilização de ozônio como adjuvante da terapia convencional para úlceras do pé diabético, e concluíram que a ozonioterapia é uma ferramenta terapêutica complementar ao tratamento convencional. Apesar disso, ainda há muito a aprofundar acerca do tema e mais pesquisas devem ser conduzidas para validar a ozonioterapia na prática clínica.


Diabetic foot ulcer is one of the complications of diabetes mellitus that occurs due to multifactorial causes. The multidisciplinary and multidisciplinary approach of patients with diabetic feet is recommended, since the condition has a high prevalence and the actions for the prevention and control of injuries are potentially effective. There is growing interest from the scientific community and Good acceptance of ozone treatment by academic journals, although the number of studies on the subject is not large. Thus, the objective of the present research was to evaluate the influence of ozone therapy in patients with diabetic foot wounds. Methodology: It was a narrative literature review about ozone therapy for the treatment of diabetic foot wounds. The terms "ozone", "ozone therapy", "ozonization", "diabetic foot", diabetic foot ulcer were used, as well as their English translations "ozone", "ozonetherapy", "diabetic foot", "diabetic foot ulcer ". The academic bases PubMed, Scielo, Lilacs and EBSCOhost were consulted. Results / Discussion: The conventional treatment for wounds is often inefficient due to the multiplication of resistant bacteria. For infected wounds, ozone can first be used as a disinfectant, as the gas is both bactericidal and fungicidal, and to obtain a pathogen-free wound; subsequently, low doses of the oxygen-ozone gas mixture can be applied to accelerate the healing of the lesion. Among the forms of treatment with ozone are the use of ozonized oil on the wound and the local application of a mixture of ozone and oxygen gases directly on the ulcer. In addition, ozone works well when inflated in a controlled microenvironment (plastic bag). ozonation, when compared to the use of conventional antibiotics, can reduce the size of the lesions and shorten the patients' hospitalization time in the short term, but apparently does not promote a complete healing of the ulcer or reduce the number of complications. Conclusion: There is a growing interest in the scientific community and good acceptance of ozone treatment by academic journals, although the number of studies on the subject is not large. Several studies have shown positive results from the use of ozone as an adjunct to conventional therapy for diabetic foot ulcers, and concluded that ozone therapy is a therapeutic tool complementary to conventional treatment. Despite this, there is still much to be done about the topic and more research must be conducted to validate ozone therapy in clinical practice.


Subject(s)
Ozone/therapeutic use , Foot Ulcer/therapy , Diabetic Foot/therapy , Periodicals as Topic , PubMed , LILACS , Anti-Bacterial Agents
11.
Wound Repair Regen ; 27(6): 672-679, 2019 11.
Article in English | MEDLINE | ID: mdl-31350938

ABSTRACT

Hochu-ekki-to (HET) is a traditional Japanese herbal (Kampo) medicine for the treatment of severe weakness, loss of appetite, and indigestion in elderly patients and for the prevention of opportunistic infections. The impact of HET on patients with chronic wounds refractory to conventional therapies was investigated in a prospective, randomized trial, including 18 patients divided into medication (7.5 g oral HET per day, n = 9) and control (n = 9) groups. Wound healing during the 12-week study period was scored based on depth, exudate, size, inflammation/infection, granulation tissue, necrotic tissue, and pocket size. At 12 weeks, wound healing progressed in all nine patients in the medication group, whereas wound healing progressed in only three patients in the control group (significant difference, p < 0.01; relative risk: 3.00). In the medication group, the total score decreased significantly at 8 weeks and later. To the best of our knowledge, this study was the first to show that HET promoted the healing of chronic wounds resistant to conventional treatments. HET may be a choice as an adjunctive therapy for chronic wounds, particularly for patients with malnutrition. This trial was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000031620).


Subject(s)
Drugs, Chinese Herbal/administration & dosage , Medicine, Kampo/methods , Wound Healing/drug effects , Wounds and Injuries/drug therapy , Administration, Oral , Adult , Aged , Chronic Disease , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Foot Ulcer/diagnosis , Foot Ulcer/drug therapy , Humans , Japan , Male , Middle Aged , Patient Selection , Pressure Ulcer/diagnosis , Pressure Ulcer/drug therapy , Prospective Studies , Reference Values , Treatment Outcome , Wound Healing/physiology , Wounds and Injuries/diagnosis
12.
Wounds ; 31(6): 145-150, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31184595

ABSTRACT

BACKGROUND: Neuropathic foot ulcers are common and difficult to treat. Calcium sulfate (CAS) has been used for antibiotic delivery in the treatment of osteomyelitis with success. Recent case series suggest success in treating osteomyelitis of the foot with CAS in a mean time to healing of 4 months; however, few studies with a control group for comparison exist. OBJECTIVE: This study aims to determine if antibiotic-impregnated CAS beads improved the healing of neuropathic foot ulcers with proven osteomyelitis undergoing surgical debridement. MATERIALS AND METHODS: A consecutive retrospective cohort study of 50 patients undergoing surgical debridement of neuropathic foot ulcers for osteomyelitis from December 2015 to May 2016 was performed. Exclusion criteria consisted of amputations and microbiology findings inconsistent with osteomyelitis. Patients were divided into 2 groups: the surgical debridement (SD) group was treated with SD alone and the other (CAS) was treated with debridement and implantation of vancomycin- and gentamicin-impregnated CAS beads. RESULTS: After exclusion criteria, 42 patients were included: 13 in the SD group and 29 in the CAS group. In the SD group, the mean time to healing was 5.8 months (range, 2-9 months), and in the CAS group, it was 5.5 months (range, 2-13 months). There was no significant difference in ulcer healing (P = .81), time to healing (P = .79), reoperation rate (P = .51), length of stay (P = .74), or mortality (P = .13) between the 2 groups. CONCLUSIONS: Ulcer healing in patients treated with antibiotic-impregnated CAS beads did not show statistical significance. Healing rates in both groups were similar to those in recent literature. Surgical debridement alone may be as effective as supplementation with local antibiotics in a bioabsorbable carrier.


Subject(s)
Debridement/methods , Foot Ulcer/etiology , Osteomyelitis/diagnosis , Peripheral Nervous System Diseases/complications , Vancomycin/therapeutic use , Wound Healing/physiology , Adult , Calcium Sulfate/pharmacology , Cohort Studies , Combined Modality Therapy , Drug Delivery Systems , Female , Follow-Up Studies , Foot Ulcer/therapy , Humans , Male , Middle Aged , Osteomyelitis/therapy , Retrospective Studies , Risk Assessment , Severity of Illness Index , Statistics, Nonparametric , Time Factors , Treatment Outcome
14.
Zhongguo Yi Liao Qi Xie Za Zhi ; 42(1): 46-48, 2018 Jan 30.
Article in Chinese | MEDLINE | ID: mdl-29862746

ABSTRACT

This paper reviews the principle and clinical application of hydrosurgery system, including the burn debridement, diabetic foot wounds debridement and other trauma debridement. Meanwhile, this paper introduces the development direction of waterjet technology. Furthermore, the safety, effectiveness and suitability can be discussed.


Subject(s)
Burns/therapy , Debridement/methods , Hydrotherapy , Foot Ulcer/therapy , Humans , Treatment Outcome , Wound Healing
15.
Eur. j. anat ; 22(2): 135-144, mar. 2018. graf, ilus
Article in English | IBECS | ID: ibc-172188

ABSTRACT

Delayed wound healing (the diabetic ulcer) is one of the major complications of diabetes mellitus (DM), which has shown an increasing trend over previous decades to affect almost 15% of diabetic patients. Virgin coconut oil (VCO) is a natural oil rich in vitamins and antioxidants and possesses antimicrobial and antiviral activities. In the current study, we evaluated the effects of topical application of VCO on wound healing in diabetes-induced Sprague-Dawley rats. A total of 72 animals were divided into 4 groups: i.e. (I) non-diabetic nontreated (NN), (II) diabetic non-treated (DN), (III) diabetic treated with VCO (VCO), and (IV) diabetic treated with silver sulfadiazine cream (SS). Wounds were inflicted on all groups using punch biopsy needles, and the animals were treated for 14 days. Wound closure rate (WCR) was measured on day 5, 10, and 14. Histological analysis was performed on day 7 and 14. Total protein content and superoxide dismutase (SOD) activity were measured on day 1, 7, and 14. WCR in VCO group was higher on all days compared to DN. Histological analysis revealed that VCO promoted re-epithelialization and increased collagen content of wound tissue. Total protein content in VCO group was higher on day 7 and 14 compared to both DN and SS groups. VCO showed insignificant effects on SOD levels. In summary, VCO was found to be better than silver sulfadiazine cream in the healing of diabetic wounds via promoting reepithelialization and collagen synthesize as well as increasing WCR and total protein content


No disponible


Subject(s)
Animals , Rats , Palm Oil/methods , Wound Healing , Wounds and Injuries/therapy , Wounds and Injuries/veterinary , Foot Ulcer/pathology , Diabetic Foot/therapy , Blood Glucose/analysis , Wounds and Injuries/diagnosis , Wounds and Injuries/pathology , Rats, Sprague-Dawley/anatomy & histology , Rats, Sprague-Dawley/metabolism , Silver Sulfadiazine/therapeutic use , Superoxide Dismutase/analysis
16.
J Nephrol ; 31(3): 435-443, 2018 06.
Article in English | MEDLINE | ID: mdl-28831705

ABSTRACT

BACKGROUND: Lower limb ischemia affects the quality of life, physical activity and life expectancy of dialysis patients. The aim of this study was to investigate the risk factors associated with ischemic foot ulcers considering clinical, laboratory and therapeutic domains. METHODS: This observational cohort study was based on data from the Nephrology and Dialysis Department database of Alessandro Manzoni Hospital, Lecco (Italy). All of the incident patients who started dialysis between 1 January 1999 and 29 February 2012 were enrolled, excluding temporary guests, patients with acute renal failure and patients with previous limb ischemia or amputation. Multivariate Cox regression analysis identified the predictors in each domain, which were matched in the final model. A time-dependent approach was used to take into account the evolution of some of the prognostic covariates. RESULTS: Of the 526 incident dialysis patients, 120 developed a lower limb ischemic lesion after a median of 13 months. The incidence of new ulcers was constant during the study period (6 per 100 person-years), but higher in the diabetics with a relative rate of 4.5. The variables significantly related to an increased risk of lower limb ulcers were age, male gender, diabetes, ischemic heart disease, treatment with proton pump inhibitors, iron, anticoagulants and calcium-based binders, and blood levels of phosphorus, triglycerides and C-reactive protein. CONCLUSION: The incidence of lower limb ulcers was highest during the early dialysis follow-up and was associated with, in addition to diabetes, modifiable laboratory and therapeutic predictors such as anticoagulants, proton pump inhibitors, calcium-containing binders, calcimimetics and iron.


Subject(s)
Foot Ulcer/epidemiology , Ischemia/epidemiology , Renal Dialysis , Age Factors , Aged , Anticoagulants/therapeutic use , C-Reactive Protein/metabolism , Calcimimetic Agents/therapeutic use , Diabetes Mellitus/epidemiology , Dietary Supplements , Female , Foot Ulcer/etiology , Humans , Incidence , Iron/therapeutic use , Ischemia/etiology , Male , Middle Aged , Myocardial Ischemia/epidemiology , Peritoneal Dialysis , Phosphorus/blood , Proportional Hazards Models , Protective Factors , Proton Pump Inhibitors/therapeutic use , Renal Dialysis/adverse effects , Risk Factors , Sex Factors , Vitamin D/therapeutic use
17.
Article in Chinese | WPRIM | ID: wpr-774472

ABSTRACT

This paper reviews the principle and clinical application of hydrosurgery system, including the burn debridement, diabetic foot wounds debridement and other trauma debridement. Meanwhile, this paper introduces the development direction of waterjet technology. Furthermore, the safety, effectiveness and suitability can be discussed.


Subject(s)
Humans , Burns , Therapeutics , Debridement , Methods , Foot Ulcer , Therapeutics , Hydrotherapy , Treatment Outcome , Wound Healing
19.
Article in English | MEDLINE | ID: mdl-28696230

ABSTRACT

Diabetic foot ulcer treatment currently focuses on targeting bacterial biofilms, while dismissing fungi. To investigate this, we used an in vitro biofilm model containing bacteria and fungi, reflective of the wound environment, to test the impact of antimicrobials. Here we showed that while monotreatment approaches influenced biofilm composition, this had no discernible effect on overall quantity. Only by combining bacterium- and fungus-specific antibiotics were we able to decrease the biofilm bioburden, irrespective of composition.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Biofilms/growth & development , Diabetic Foot/drug therapy , Foot Ulcer/drug therapy , Foot Ulcer/microbiology , Biofilms/drug effects , Candida albicans/drug effects , Candida albicans/isolation & purification , Ciprofloxacin/therapeutic use , Diabetic Foot/microbiology , Floxacillin/therapeutic use , Fluconazole/therapeutic use , Humans , Microbial Sensitivity Tests , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
20.
Cochrane Database Syst Rev ; 6: CD011979, 2017 06 28.
Article in English | MEDLINE | ID: mdl-28657134

ABSTRACT

BACKGROUND: Foot ulcers are a disabling complication of diabetes that affect 15% to 25% of people with diabetes at some time in their lives. Phototherapy is a relatively new, non-invasive, and pain-free treatment method, which promotes the ulcer repair process through multiple mechanisms such as increased cell growth and vascular activity. Phototherapy may be used as an alternative approach for the treatment of foot ulcers in people with diabetes, but the evidence for its effect compared with placebo or other treatments has not yet been established. OBJECTIVES: To assess the effects of phototherapy for the treatment of foot ulcers in people with diabetes. SEARCH METHODS: We searched the Cochrane Wounds Specialised Register (11 October 2016), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2016, Issue 10), Ovid MEDLINE (11 October 2016), Ovid MEDLINE (In-Process & Other Non-Indexed Citations) (11 October 2016), Ovid Embase (11 October 2016), EBSCO CINAHL Plus (11 October 2016), and China National Knowledge Infrastructure (24 June 2017). We also searched clinical trials registries for ongoing and unpublished studies on 24 June 2017, and screened reference lists to identify additional studies. We used no restrictions with respect to language, date of publication, or study setting. SELECTION CRITERIA: Randomised controlled trials or cluster randomised controlled trials that 1) compared phototherapy with sham phototherapy, no phototherapy, or other physical therapy modalities, 2) compared different forms of phototherapy, or 3) compared phototherapy of different output power, wavelength, power density, or dose range, in adults with diabetes and an open foot ulcer of any severity, in any setting. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, data extraction, and 'Risk of bias' assessment. We combined the study outcomes when appropriate. MAIN RESULTS: Eight trials with 316 participants met the inclusion criteria. Most of the included studies were single-centre studies that were carried out in clinics or hospitals with a sample size ranging from 14 to 84. We generally considered the included studies to be at unclear or high risk of bias, as they had one domain at high risk of bias, or three or more domains at unclear risk of bias.We did not identify any studies that reported valid data for time to complete wound healing. Meta-analysis of four studies including 116 participants indicated that participants receiving phototherapy may experience a greater proportion of wounds completely healed during follow-up compared with those receiving no phototherapy/placebo (64.5% for the phototherapy group versus 37.0% for the no phototherapy/placebo group; risk ratio 1.57, 95% confidence interval 1.08 to 2.28; low-quality evidence, downgraded for study limitations and imprecision). Two studies mentioned adverse events in the results; one study with 16 participants suggested that there were no device-related adverse events, and the other study with 14 participants suggested that there was no clear difference between phototherapy and placebo group.Four studies reported change in ulcer size, but primarily due to high heterogeneity, they were not combined. Results from individual trials (including 16 participants to 84 participants) generally suggested that after two to four weeks of treatment phototherapy may result in a greater reduction in ulcer size but the quality of the evidence was low due to unclear risk of bias in the original trial and small sample size. We based the analyses for quality of life and amputations on only one study each (28 participants and 23 participants respectively); both outcomes showed no clear difference between the phototherapy group and the no phototherapy/placebo group. AUTHORS' CONCLUSIONS: This systematic review of randomised trials suggested that phototherapy, when compared to no phototherapy/placebo, may increase the proportion of wounds completely healed during follow-up and may reduce wound size in people with diabetes, but there was no evidence that phototherapy improves quality of life. Due to the small sample size and methodological flaws in the original trials, the quality of the evidence was low, which reduces our confidence in these results. Large, well-designed randomised controlled trials are needed to confirm whether phototherapy could be an effective option for the treatment of foot ulcers in people with diabetes.


Subject(s)
Diabetic Foot/therapy , Phototherapy/methods , Foot Ulcer/therapy , Humans , Phototherapy/adverse effects , Randomized Controlled Trials as Topic , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL